Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
02Nov

Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit

Noramco, a leading global active pharmaceutical ingredients (API) manufacturer, specializing in controlled substances, announced today
What to Consider when Selecting a CDMO for API Manufacturing
07Aug

What to Consider when Selecting a CDMO for API Manufacturing

Rigorously reported, peer reviewed and immediately available without restrictions, promoting the widest readership and impact possible
Working With an Experienced Team Can Maximize Your ROI
06Aug

Working With an Experienced Team Can Maximize Your ROI

Rigorously reported, peer reviewed and immediately available without restrictions, promoting the widest readership and impact possible
Navigating the Complexities of Controlled Substances
05Aug

Navigating the Complexities of Controlled Substances

Rigorously reported, peer reviewed and immediately available without restrictions, promoting the widest readership and impact possible
Understanding the FDA Process to Commercialize Drugs
04Aug

Understanding the FDA Process to Commercialize Drugs

Rigorously reported, peer reviewed and immediately available without restrictions, promoting the widest readership and impact possible
07Jul

Purisys Adds ISO Certifications Confirming Its Commitment to Quality and Excellence

Rigorously reported, peer reviewed and immediately available without restrictions, promoting the widest readership and impact possible
Connect With Us